Omeros Corp

Most Recent

  • uploads///Omeros
    Company & Industry Overviews

    Why Omeros Stock Rose Last Week

    On April 2, 2018, Omeros (OMER) stock opened at $11.12. It grew ~22% over the week to close at $13.58 on April 6.

    By Daniel Collins
  • uploads///OMER
    Company & Industry Overviews

    What’s behind Omeros’s Cash Flow

    In fiscal 2017, Omeros spent $36.2 million on operating activities, compared with $51.5 million in fiscal 2016.

    By Kenneth Smith
  • uploads///OMER
    Company & Industry Overviews

    A Look at Omeros’s Promising Research Pipeline

    Omeros’s (OMER) research pipeline includes OMS721, which is undergoing Phase 3 trials.

    By Kenneth Smith
  • uploads///virus _
    Company & Industry Overviews

    Analysts’ Ratings for Omeros and Peers in March 2018

    Omeros (OMER) is a commercial biopharmaceutical company. Its product, Omidria, is used in cataract surgery.

    By Kenneth Smith
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.